Logo image
Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug release
Journal article   Peer reviewed

Magnetic field activated lipid–polymer hybrid nanoparticles for stimuli-responsive drug release

Seong Deok Kong, Marta Sartor, Che-Ming Jack Hu, Weizhou Zhang, Liangfang Zhang and Sungho Jin
Acta biomaterialia, Vol.9(3), pp.5447-5452
03/2013
DOI: 10.1016/j.actbio.2012.11.006
PMCID: PMC4077216
PMID: 23149252

View Online

Abstract

Stimuli-responsive nanoparticles (SRNPs) offer the potential of enhancing the therapeutic efficacy and minimizing the side-effects of chemotherapeutics by controllably releasing the encapsulated drug at the target site. Currently controlled drug release through external activation remains a major challenge during the delivery of therapeutic agents. Here we report a lipid–polymer hybrid nanoparticle system containing magnetic beads for stimuli-responsive drug release using a remote radio frequency (RF) magnetic field. These hybrid nanoparticles show long-term stability in terms of particle size and polydispersity index in phosphate-buffered saline (PBS). Controllable loading of camptothecin (CPT) and Fe 3 O 4 in the hybrid nanoparticles was demonstrated. RF-controlled drug release from these nanoparticles was observed. In addition, cellular uptake of the SRNPs into MT2 mouse breast cancer cells was examined. Using CPT as a model anticancer drug the nanoparticles showed a significant reduction in MT2 mouse breast cancer cell growth in vitro in the presence of a remote RF field. The ease of preparation, stability, and controllable drug release are the strengths of the platform and provide the opportunity to improve cancer chemotherapy.
Magnetic beads Drug delivery Controlled drug release Lipid–polymer hybrid nanoparticles

Details

Logo image